Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

The superior efficacy of anti-PD-1/PD-L1 immunotherapy in KRAS-mutant non-small cell lung cancer that correlates with an inflammatory phenotype and increased immunogenicity

PaperCitations, authors & open-access status

The superior efficacy of anti-PD-1/PD-L1 immunotherapy in KRAS-mutant non-small cell lung cancer that correlates with an inflammatory phenotype and increased immunogenicity is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 285 citations, 2019 year and hybrid oa status.

285
Citations
2019
Year
hybrid
OA Status

Related on ScholarIQ

Yan Wang
Author
Cancer Immunotherapy and Biomarkers
Topic
Cancer Immunotherapy and Biomarkers
Topic
Immunotherapy and Immune Responses
Topic
Lung Cancer Treatments and Mutations
Topic
470M+ articles · free account